Subsequent work demonstrated that “high-risk” chromosomal gains/losses, including p53 loss, are largely specific for, and highly prevalent among, GATA-3 expressing PTCL, and may explain (or contribute to) the poor outcomes observed in patients afflicted with these lymphomas [17]. This evidence concerns the gene TP53 and lymphoma.